Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer

Author: Fasano Morena   Della Corte Carminia Maria   Califano Raffaele   Capuano Annalisa   Troiani Teresa   Martinelli Erika   Ciardiello Fortunato   Morgillo Floriana  

Publisher: Informa Healthcare

ISSN: 1354-3784

Source: Expert Opinion on Investigational Drugs, Vol.23, Iss.6, 2014-06, pp. : 809-821

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next